|
EDEM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92734717074927E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.63866706262661E-12 |
| Normal-vs-Stage2 |
3.223900E-02 |
| Normal-vs-Stage3 |
3.92779999636161E-08 |
| Normal-vs-Stage4 |
2.27680000408625E-08 |
| Stage1-vs-Stage2 |
3.958300E-02 |
| Stage1-vs-Stage3 |
4.778800E-01 |
| Stage1-vs-Stage4 |
1.543450E-01 |
| Stage2-vs-Stage3 |
1.399790E-01 |
| Stage2-vs-Stage4 |
1.018470E-02 |
| Stage3-vs-Stage4 |
6.037600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.35411731511704E-13 |
| Normal-vs-AfricanAmerican |
6.49320000000175E-05 |
| Normal-vs-Asian |
1.1421000000178E-06 |
| Caucasian-vs-AfricanAmerican |
6.281700E-02 |
| Caucasian-vs-Asian |
6.728000E-01 |
| AfricanAmerican-vs-Asian |
1.959760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.76839999982614E-07 |
| Normal-vs-Female |
1.66244795707371E-12 |
| Male-vs-Female |
4.100300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.92161866816332E-12 |
| Normal-vs-Age(41-60Yrs) |
5.23620036219086E-10 |
| Normal-vs-Age(61-80Yrs) |
2.04529999999759E-05 |
| Normal-vs-Age(81-100Yrs) |
2.035400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.363600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.512100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.158800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.611600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.984800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.824400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.632800E-01 |
| Classical-VS-Follicular |
5.98260330164635E-11 |
| Classical-VS-Other |
1.732040E-02 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.84921999999421E-05 |
| Tall-VS-Other |
7.942700E-03 |
| Tall-VS-Normal |
1.70690000023122E-07 |
| Follicular-VS-Other |
8.138800E-01 |
| Follicular-VS-Normal |
3.120600E-01 |
| Other-VS-Normal |
8.896000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.04680000013025E-07 |
| Normal-vs-N1 |
5.95960000016049E-07 |
| N0-vs-N1 |
1.622830E-01 |
|
|
